Andrew Yates at Think Gene has a post about direct-to-consumer genomic testing and why programs like the Coriell Institute's Personalized Medicine Collaborative (free to patients) might be taking some of the wind out of corporate sails. "The problem is that DTC genomic companies aren't profitable," Yates writes. With one organization offering to do testing for free, it'll be tougher to convince investors that there's a good chance for return on investment, he says.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.